Document Detail


APOBEC3B deletion and risk of HIV-1 acquisition.
MedLine Citation:
PMID:  19698078     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The human APOBEC3 family of cytidine deaminases provides intrinsic immunity to retroviral infection. A naturally occurring 29.5-kb deletion removes the entire APOBEC3B gene. We examined the impact of the APOBEC3B gene deletion in >4000 individuals from 5 human immunodeficiency virus type 1 (HIV-1) natural history cohorts. The hemizygous genotype had no effect on either acquisition of HIV-1 infection or progression to AIDS. However, the homozygous deletion was significantly associated with unfavorable outcomes for HIV-1 acquisition (odds ratio, 7.37; P= .024), progression to AIDS (relative hazard, 4.01; P=. 03), and viral set point (P= .04). These findings suggest that the loss of APOBEC3B may increase host susceptibility to HIV-1 acquisition and progression to AIDS and warrant further study.
Authors:
Ping An; Randall Johnson; John Phair; Gregory D Kirk; Xiao-Fang Yu; Sharyne Donfield; Susan Buchbinder; James J Goedert; Cheryl A Winkler
Related Documents :
3811148 - Toxoplasmosis in a flock of sheep: some investigations into its source and control.
2681968 - Acquired immunodeficiency syndrome (aids)--related renal disease.
18691828 - Aids: "it's the bacteria, stupid!".
9187928 - The pancreas in aids.
18189598 - Efficient modeling of range-dependent seismo-acoustics problems.
17123208 - Human-centered robotics applied to gait training and assessment.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural    
Journal Detail:
Title:  The Journal of infectious diseases     Volume:  200     ISSN:  0022-1899     ISO Abbreviation:  J. Infect. Dis.     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-09-02     Completed Date:  2009-10-28     Revised Date:  2012-04-24    
Medline Journal Info:
Nlm Unique ID:  0413675     Medline TA:  J Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1054-8     Citation Subset:  AIM; IM    
Affiliation:
Laboratory of Genomic Diversity, SAIC-Frederick, National Cancer Institute-Frederick, Frederick, MD 21702, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cytidine Deaminase / genetics*
Ethnic Groups
Gene Deletion
Gene Expression Regulation / physiology
Genetic Predisposition to Disease*
HIV Infections / genetics*
HIV-1*
Heterozygote
Homozygote
Humans
Grant Support
ID/Acronym/Agency:
R01 DA004334/DA/NIDA NIH HHS; R01-12586//PHS HHS; R01-DA04334/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
EC 3.5.4.5/APOBEC3B protein, human; EC 3.5.4.5/Cytidine Deaminase
Comments/Corrections
Comment In:
J Infect Dis. 2010 Sep 1;202(5):815-6; author reply 816-7   [PMID:  20684727 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines.
Next Document:  Potential antifungal effects of human platelets against zygomycetes in vitro.